Anzeige
Mehr »
Login
Donnerstag, 16.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
STRONG BUY: Jetzt der Turnaround und Rallye bis 10 USD?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema CLEARMIND MEDICINE

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
FrClearmind Medicine Inc. - 6-K, Report of foreign issuer1
FrClearmind Medicine Inc (3): Clearmind makes alcohol substitute program progress1
FrClearmind Medicine Inc.: Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product1
07.05.Why Clearmind Medicine Stock Is Moving Higher1
07.05.Clearmind Medicine Inc.: Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment99Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development...
► Artikel lesen
30.04.Clearmind Medicine Inc (3): Clearmind aims to cease being Cdn reporting issuer1
30.04.Clearmind Medicine Inc.: Clearmind Applies to Cease Being a Reporting Issuer in Canada112Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) ("Clearmind" or the "Company"), a clinical- stage biotech company focused on discovery...
► Artikel lesen
30.04.Clearmind Medicine Inc. - 6-K, Report of foreign issuer1
17.04.Clearmind Medicine Inc. - 6-K, Report of foreign issuer1
17.04.Clearmind Medicine Inc.: Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders66Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "company"), a biotech company focused on discovery...
► Artikel lesen
10.04.Clearmind Medicine Inc.: Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders920Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "company"), a clinical- stage biotech company focused on discovery and...
► Artikel lesen
09.04.Clearmind Medicine Inc. - 6-K, Report of foreign issuer1
09.04.Clearmind Medicine Inc.: Clearmind Medicine CEO Issues Letter to Shareholders348Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) ("Clearmind" or the "company"), a clinical-stage biotech company focused on discovery and development...
► Artikel lesen
27.03.Clearmind Medicine Inc. - 6-K, Report of foreign issuer1
27.03.Clearmind Medicine Inc.: Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression258Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ("Clearmind" or the "company"), a biotech company focused on discovery and development...
► Artikel lesen
19.03.Clearmind Medicine Inc.: Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China2
14.03.Clearmind Medicine Inc (3): Clearmind Medicine to be delisted from CSE1
13.03.Clearmind Medicine Inc. - 6-K, Report of foreign issuer1
13.03.CSE Bulletin: Delist - Clearmind Medicine Inc. (CMND)286Toronto, Ontario--(Newsfile Corp. - Le 13 mars/March 2024) - The common shares of Clearmind Medicine Inc. will be delisted from the CSE at market close, March 14, 2024. The common shares currently...
► Artikel lesen
13.03.Clearmind Medicine Inc (3): Clearmind receives approval for voluntary CSE delisting2
Seite:  Weiter >>